Anti-angiogenic therapy in breast cancer
- 8 October 2003
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 57 (10), 463-470
- https://doi.org/10.1016/j.biopha.2003.09.009
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cellsHepatology, 2002
- Cyclooxygenase-2 Is Overexpressed in HER-2/neu-positive Breast CancerJournal of Biological Chemistry, 2002
- Angiogenic co‐operation of VEGF and stromal cell TP in endometrial carcinomasThe Journal of Pathology, 2002
- Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cellsJournal of Clinical Investigation, 2001
- Association of Enhanced Cyclooxygenase-2 Expression With Possible Local Immunosuppression in Human Colorectal CarcinomasAnnals of Surgical Oncology, 2001
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Tumour vascularity and basement membrane structure in breast cancer as related to tumour histology and prognosisZeitschrift für Krebsforschung und Klinische Onkologie, 1994
- Interleukin-4 is a potent mitogen for capillary endotheliumBiochemical and Biophysical Research Communications, 1991
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990